The Harvard University Center for AIDS Research Immunology Core and Vaccine Program, the National Institutes of Health, and Nature Medicine are pleased to sponsor the Inaugural 2013 Glycoimmunology Symposium!
Thursday, May 23, 2013
Joseph B. Martin Conference Center Amphitheater
Symposium Title: Potentiating Immune Responses with Glycans
While a great deal of research has focused on the role of nucleic acid and protein variation in human disease, including HIV, the impact of glycosylation changes has been poorly defined. Glycans decorate nearly all proteins in the body, respond rapidly and dramatically to inflammatory cues, and have been centrally implicated in regulating the immune response. With the advent of new technologies, and a great interest in the intersection of glycobiology and immunology, significant advances are now being realized in our understanding of how glycosylation may both allow pathogens to subvert the immune system but also represent exciting new targets for the immune system to target for enhanced protection from infection. Thus in this symposium we proposed to bring together glycobiology and glycoimmunology thought leaders to begin to define the landscape of opportunities by which glycan-based therapeutics can be harnessed for autoimmune, cancer, infectious diseases, and HIV vaccine application.
There is still time to register!